1:50 p.m. DISCUSSION
5.1 Pharmacy Compounding Practice. The board will discuss the scope of pharmacy practice in compounding pharmaceutical products and consider a response to the Ther-Rx Corporation letter reviewed at the September meeting. Information/Action
Source found here
No comments:
Post a Comment